Patents Assigned to FONDAZIONE EBRI RITA LEVI-MONTALCINI
  • ANTIBODY DIRECTED AGAINST A TAU-DERIVED NEUROTOXIC PEPTIDE AND USES THEREOF
    Publication number: 20210230255
    Abstract: The present invention refers to an antibody or an antigen binding fragment thereof against a tau-derived neurotoxic peptide for use in the treatment and/or prevention of Alzheimer's disease (AD) or a non-AD tauopathy, as well as pharmaceutical compositions comprising the same.
    Type: Application
    Filed: April 29, 2019
    Publication date: July 29, 2021
    Applicants: FONDAZIONE EBRI RITA LEVI-MONTALCINI, CONSIGLIO NAZIONALE DELLE RICERCHE
    Inventors: Giuseppina AMADORO, Pietro CALISSANO, Veronica CORSETTI